INCR News
Archived Headlines
- INC Research prices IPO at $18.50 midpoint 11/07/14
- Test taking for hire: PRA Health Sciences sets terms for $400 million IPO 11/03/14
- Week Ahead: 12 US IPOs planned for the week of November 3 as the IPO market reignites 11/02/14
- Contract research organization INC Research sets terms for $150 million IPO 10/27/14
- Testing for hire: INC Research files for a $150 million IPO 10/06/14
Blank check company Avista Healthcare Public Acquisition prices $300 million IPO at $10
Avista Healthcare Public Acquisition, a blank check company formed by Avista to acquire a health care company, raised $300 million by offering 30 million shares at $10, as expected. Avista was behind 2014 IPO INC Research (INCR) and 2015 IPO Lantheus (LNTH)....read more
US IPO Week Ahead: Medpace and three others are on pace for IPOs
Four companies are set to raise a combined $270 million in the week ahead. Most notable deal Medpace, a contract research organization focused on biotechs, is joined by two potential customers: Protagonist Therapeutics and Motif Bio. Thanks to insider support,...read more
Renaissance IPO Index - Notice of September 2015 Quarterly Changes
The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s...read more
US IPO Weekly Recap: 8 companies go public with strong returns as 5 delay IPOs
This week saw 8 IPOs raise $1.7 billion. While 5 of the 13 were delayed, the rest averaged 18% return, and all but one ended the week positive. Broader markets continue to rally as the Dow and S&P 500 closed at new record highs and the VIX volatility index...read more